Evofem Biosciences, Orion Biotechnology Enter OB-002 Alliance - Contract Pharma

Retrieved on: 2021-12-17 16:38:54

Tags for this article:

Click the tags to see associated articles and topics

Evofem Biosciences, Orion Biotechnology Enter OB-002 Alliance - Contract Pharma. View article details on hiswai:

Excerpt

Evofem Biosciences, Orion Biotechnology Enter OB-002 Alliance. To evaluate Orion's CCR5 antagonist, OB-002, in Evofem's Phexxi vaginal gel with ...

Article found on: www.contractpharma.com